Self-Efficacy Is the Quiet Variable Behind Trial Participation.

Knowing what a trial requires is not the same as believing you can manage it. That gap changes decisions and participation.

Confidence must be specific to the task.

General optimism is not enough. A patient may feel confident about speaking with a physician and uncertain about using an electronic diary, traveling to a distant site, managing a washout period, or reporting a possible adverse event. Each task creates its own confidence requirement.

This specificity makes self-efficacy operational. Teams can identify the exact action that feels difficult and respond with the right preparation. A technology concern needs guided practice. A scheduling concern needs logistical planning. A communication concern may require permission, language, and a clear escalation path.

Confidence without understanding is not readiness.

A polished enrollment experience can make a patient feel reassured before the true burden is visible. That is not durable self-efficacy. Confidence should be grounded in a realistic understanding of visits, procedures, uncertainty, alternatives, responsibilities, and the support that will actually be available.

The goal is calibrated confidence. Patients should know what they can manage, where they may need help, and which questions remain unresolved. A well-supported no is more ethical than an enthusiastic yes built on incomplete expectations.

Build capability through experience, not slogans.

Self-efficacy grows when people see a task, try it, receive useful feedback, and know where assistance lives. Clinical trial preparation can use short demonstrations, visit walkthroughs, teach-back, rehearsal, checklists, caregiver planning, and low-stakes practice with digital tools.

The sequence matters. Start with the next relevant action rather than compressing the entire study into one cognitive event. Progressive preparation gives patients a chance to build mastery while preserving the ability to reconsider as new information becomes relevant.

Treat low confidence as a support signal.

Low task confidence should not become an exclusion score. It is a signal that the current experience has not yet created the capability required for safe, informed, and feasible participation. The appropriate response is diagnosis and support, not judgment.

Teams can monitor confidence at handoffs and high-burden moments, then ask whether the barrier changed after intervention. That creates a closed loop: identify the task, provide support, confirm understanding and capability, and advance only when the patient is prepared for the next demand.

Sources.

1. Bandura, Self-Efficacy: Toward a Unifying Theory of Behavioral Change
2. Hibbard et al., Development of the Patient Activation Measure
3. FDA, Patient-Focused Drug Development Guidance Series
4. HHS OHRP, Informed Consent FAQs

About the author

Rebecca Schelkun

Vice President, Patient Readiness

Rebecca is Vice President of Patient Readiness at Jumo Health. She combines public health expertise in epidemiology and biostatistics with experience across health equity, patient advocacy, pediatrics, rare disease, and clinical trial strategy. At Jumo, she turns protocol demands and lived experience into education, decision support, and expectation alignment patients can use.